Adaptimmune Therapeutics
ADAP
#4255
Rank
$0.81 B
Marketcap
๐Ÿ‡ฌ๐Ÿ‡ง UK
Country
$5.21
Share price
-1.14%
Change (1 day)
N/A
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2021 (TTM): -$0.16 B

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2020 the company made an earning of -$0.14 B an increase over its 2019 earnings that were of -$0.14 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Adaptimmune Therapeutics from 2016 to 2021

Year Earnings Change
2021 (TTM)-$0.16 B12.88%
2020-$0.14 B-4.55%
2019-$0.14 B69%
2018-$0.09 B1.69%
2017-$0.09 B11.72%
2016-$0.08 B